ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 158 filers reported holding ZIOPHARM ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $86,000 | -82.2% | 18,265 | -83.8% | 0.00% | -83.3% |
| Q3 2019 | $483,000 | +392.9% | 112,765 | +568.6% | 0.02% | +300.0% |
| Q2 2019 | $98,000 | -75.9% | 16,865 | -74.5% | 0.01% | -71.4% |
| Q3 2017 | $406,000 | -84.1% | 66,147 | -83.9% | 0.02% | -84.6% |
| Q2 2017 | $2,559,000 | +266.1% | 411,547 | +273.0% | 0.14% | +325.0% |
| Q1 2017 | $699,000 | -11.7% | 110,339 | -23.5% | 0.03% | -20.0% |
| Q2 2016 | $792,000 | -54.3% | 144,307 | -38.2% | 0.04% | -48.1% |
| Q1 2016 | $1,732,000 | -75.3% | 233,464 | -64.1% | 0.08% | -68.0% |
| Q1 2015 | $7,000,000 | +2187.6% | 650,027 | +460.8% | 0.24% | +1621.4% |
| Q3 2014 | $306,000 | -32.5% | 115,919 | +3.0% | 0.01% | -41.7% |
| Q2 2014 | $453,000 | +8.1% | 112,519 | +22.8% | 0.02% | +9.1% |
| Q1 2014 | $419,000 | – | 91,657 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 15,461,829 | $2,037,869 | 0.36% |
| MSD Partners, L.P. | 15,151,516 | $1,996,970 | 0.16% |
| MSD Partners, L.P. | 7,575,758 | $998,485 | 0.08% |
| MAGNOLIA CAPITAL ADVISORS LLC | 865,938 | $65,552 | 0.03% |
| Allred Capital Management, LLC | 253,000 | $33,345 | 0.02% |
| CHIRON CAPITAL MANAGEMENT, LLC | 77,023 | $10,152 | 0.01% |
| Boxer Capital, LLC | 1,100,000 | $144,980 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 569,566 | $75 | 0.01% |
| Sugarloaf Wealth Management, LLC | 75,500 | $9,951 | 0.00% |
| Owen LaRue, LLC | 11,825 | $1,559 | 0.00% |